IntelliMedicine

IntelliMedicine is a private healthcare technology company developing a proprietary platform for on-demand, individualized medications, with an emphasis on 3D-printed personalized polypills. The company aims to combine multiple medicines into a single capsule in patient-specific doses, using clinical and patient data to tailor therapy and improve adherence. Its positioning sits at the intersection of precision medicine, digital health, and drug delivery rather than conventional therapeutics development. Public materials emphasize platform development and concept commercialization, but do not show a conventional clinical-stage drug pipeline. The company appears to be founder-led by physician-scientist Daniel Kraft and is based in the Palo Alto/Stanford area.